AMG
GILD icon

Advisors Management Group’s Gilead Sciences GILD Stock Holding History

Advisors Management Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.17M Sell
22,716
-5,389
-19% -$755K 0.58% 48
2025
Q4 		$3.45M Sell
28,105
-4,890
-15% -$594K 0.63% 46
2025
Q3 		$3.66M Sell
32,995
-471
-1% -$53.5K 0.64% 49
2025
Q2 		$3.71M Sell
33,466
-185
-0.5% -$19.7K 0.7% 45
2025
Q1 		$3.77M Sell
33,651
-90
-0.3% -$9.29K 0.82% 37
2024
Q4 		$3.12M Sell
33,741
-393
-1% -$35.4K 0.74% 43
2024
Q3 		$2.86M Sell
34,134
-173
-0.5% -$13.2K 0.68% 48
2024
Q2 		$2.35M Buy
34,307
+502
+1% +$33.5K 0.59% 57
2024
Q1 		$2.48M Buy
33,805
+725
+2% +$55.8K 0.61% 55
2023
Q4 		$2.68M Buy
33,080
+61
+0.2% +$4.75K 0.73% 44
2023
Q3 		$2.47M Buy
33,019
+173
+0.5% +$13.3K 0.75% 47
2023
Q2 		$2.53M Buy
32,846
+2,125
+7% +$169K 0.76% 45
2023
Q1 		$2.55M Sell
30,721
-230
-0.7% -$19.1K 0.81% 43
2022
Q4 		$2.66M Sell
30,951
-196
-0.6% -$15.5K 1% 35
2022
Q3 		$1.92M Buy
31,147
+172
+0.6% +$10.8K 0.76% 47
2022
Q2 		$1.92M Buy
+30,975
New +$1.92M 0.67% 49

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Advisors Management Group's GILD Position: Q1 2026 in Review

Advisors Management Group reduced its Gilead Sciences (GILD) stake by 19% in Q1 2026, selling an estimated $755K and leaving 22,716 shares worth $3.17M. The position accounts for 0.58% of the portfolio, ranked #48.

Advisors Management Group first reported a position in GILD in Q2 2022 and has held it in 16 quarters since. The position peaked at $3.77M in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Advisors Management Group held 22,716 shares of Gilead Sciences worth $3.17M as of Q1 2026.
  • Advisors Management Group sold 5,389 Gilead Sciences shares in Q1 2026, an estimated $755K.
  • Gilead Sciences made up 0.58% of Advisors Management Group's portfolio in Q1 2026, its #48 holding.
  • Advisors Management Group first reported a position in Gilead Sciences in Q2 2022 and has held it in 16 quarters since.
  • Advisors Management Group's Gilead Sciences position peaked at $3.77M in Q1 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Advisors Management Group's 13F filing for Q1 2026, filed 1 May 2026.